Industry News
$1 test for prostate cancer
Scientists at the University of Central Florida have developed a prostate cancer test that is said to be faster, cheaper, more sensitive and more accurate than the standard PSA test for early-stage prostate cancer. [ + ]
Monash facility supports green chemicals manufacturing
Monash University has opened its Green Chemical Futures building - a multidisciplinary innovation hub dedicated to supporting Australia's academic and industrial research within the chemicals manufacturing sector. [ + ]
Unexpected increase in global vegetation and carbon capture
In spite of large-scale deforestation in the tropics, vegetation has increased by almost the equivalent of 4 billion tonnes of carbon since 2003.
[ + ]Positive breakthrough in triple-negative breast cancer research
A study led by Sydney's Garvan Institute of Medical Research has revealed a new discovery regarding triple-negative breast cancers (TNBCs) - cancers which lack any of the three receptors (oestrogen, progesterone or HER2) that would make them responsive to targeted drugs.
[ + ]Technology-commercialisation skills study awarded grant
The Professional Standards Councils (PSC) will fund a year-long study to identify the skills and qualities required to successfully put research to use via commercialisation. [ + ]
Genetic Signatures lists on the ASX
Molecular diagnostics company Genetic Signatures listed on the ASX today under the stock code 'GSS', following a successful IPO which achieved the maximum raising of $7.5 million. [ + ]
DKSH appointed exclusive Setaram distributor
Setaram Instrumentation has announced DKSH Australia as its new exclusive representative in Australia and New Zealand. [ + ]
NHMRC recognises top research translation centres
In order to encourage leadership at an internationally competitive level, the National Health and Medical has recognised four Australian health centres as NHMRC Advanced Health Research and Translation Centres. [ + ]
The link between aspirin, bowel cancer and our genes
An international research team has suggested that the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), long associated with lowering the risk of bowel (colorectal) cancer, may be dependent on a person's individual genetics. [ + ]
The link between aspirin, bowel cancer and our genes
An international research team has suggested that the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), long associated with lowering the risk of bowel (colorectal) cancer, may be dependent on a person's individual genetics. [ + ]
New corporate advisory practice for Australian tech companies
Corporate advisory house Cube Capital has just launched in Australia, with a plan to capitalise on the boom in tech and healthcare stocks and take them public.
[ + ]ISO accreditation for AGRF next-gen sequencing
The Australian Genome Research Facility (AGRF) has received ISO/IEC 17025:2005 accreditation for Illumina-based sequencing services in its next-generation sequencing lab.
[ + ]Tracing the spread of drug-resistant TB
An international research team has, for the first time, used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis (TB) between patients in the UK. [ + ]
GATC Biotech offers full access to QIAGEN's Ingenuity Variant Analysis
GATC Biotech clients will be provided with full access to QIAGEN's Ingenuity Variant Analysis solution for analysis and interpretation of genetic data, complementing GATC's InView Human Exome and providing customers with an integrated solution to identify causal variants in their exome sequencing data. [ + ]
Sigma-Aldrich signs exclusive distribution agreement with Roche
Following an exclusive distribution agreement signed last week, life science company Sigma-Aldrich will employ its sales, marketing and e-commerce expertise for the exclusive worldwide distribution of the Biochemical Reagents product portfolio from Roche. [ + ]